Recombinant multi-species TFF1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TFF1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Members of the trefoil family are characterized by having at least one copy of the trefoil motif, a 40-amino acid domain that contains three conserved disulfides. They are stable secretory proteins expressed in gastrointestinal mucosa. Their functions are not defined, but they may protect the mucosa from insults, stabilize the mucus layer, and affect healing of the epithelium. This gene, which is expressed in the gastric mucosa, has also been studied because of its expression in human tumors. This gene and two other related trefoil family member genes are found in a cluster on chromosome 21. [provided by RefSeq, Jul 2008]
The Alternative Names of target: BCEI,Bcei,Breast cancer estrogen-inducible protein,D21S21,HP1.A,HPS2,PNR-2,PS2,Polypeptide P1.A (hP1.A),Protein pS2,Ps2,TFF1,Tff1,Trefoil factor 1,pNR-2,pS2
Go
to TFF1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T38159-Ag-1/ GM-Tg-hg-T38159-Ag-2 | Human TFF1 protein | Human |
| GM-Tg-rg-T38159-Ag-1/ GM-Tg-rg-T38159-Ag-2 | Rat TFF1 protein | Rat |
| GM-Tg-mg-T38159-Ag-1/ GM-Tg-mg-T38159-Ag-2 | Mouse TFF1 protein | Mouse |
| GM-Tg-cynog-T38159-Ag-1/ GM-Tg-cynog-T38159-Ag-2 | Cynomolgus/Rhesus macaque TFF1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T38159-Ag-1/ GM-Tg-felg-T38159-Ag-2 | Feline TFF1 protein | Feline |
| GM-Tg-cang-T38159-Ag-1/ GM-Tg-cang-T38159-Ag-2 | Canine TFF1 protein | Canine |
| GM-Tg-bovg-T38159-Ag-1/ GM-Tg-bovg-T38159-Ag-2 | Bovine TFF1 protein | Bovine |
| GM-Tg-equg-T38159-Ag-1/ GM-Tg-equg-T38159-Ag-2 | Equine TFF1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T38159-Ag-1/ GM-Tg-hg-T38159-Ag-2;
GM-Tg-rg-T38159-Ag-1/ GM-Tg-rg-T38159-Ag-2;
GM-Tg-mg-T38159-Ag-1/ GM-Tg-mg-T38159-Ag-2; GM-Tg-cynog-T38159-Ag-1/ GM-Tg-cynog-T38159-Ag-2; GM-Tg-felg-T38159-Ag-1/ GM-Tg-felg-T38159-Ag-2; GM-Tg-cang-T38159-Ag-1/ GM-Tg-cang-T38159-Ag-2; GM-Tg-bovg-T38159-Ag-1/ GM-Tg-bovg-T38159-Ag-2; GM-Tg-equg-T38159-Ag-1/ GM-Tg-equg-T38159-Ag-2 |
| Products Name | TFF1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | TFF1 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine TFF1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.